Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyspnea.

N K Burki1

  • 1Department of Medicine, (Pulmonary and Critical Care Division), University of Kentucky Medical Center, Lexington.

Lung
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Dyspnea, or difficulty breathing, arises from complex mechanisms involving respiratory muscles and central command, not a single cause. Current treatments are experimental, with exercise and certain drugs showing limited promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Airway irritation and cough evoked by inhaled cigarette smoke: role of neuronal nicotinic acetylcholine receptors.

Pulmonary pharmacology & therapeutics·2006
Same author

Effects of therapeutic doses of albuterol on beta2-adrenergic receptor density and metabolic changes.

The Journal of asthma : official journal of the Association for the Care of Asthma·2001
Same author

Maximal expiratory flow patterns after single-lung transplantation in patients with and without chronic airways obstruction.

Chest·2001
Same author

Effects of acute prolonged exposure to high-altitude hypoxia on exercise-induced breathlessness.

Clinical science (London, England : 1979)·1999
Same author

Variability of peripheral blood lymphocyte beta-2-adrenergic receptor density in humans.

American journal of respiratory and critical care medicine·1998
Same author

The effects of the combination of inhaled ipratropium and oral theophylline in asthma.

Chest·1997
Same journal

Circulating Adipokines as Diagnostic and Prognostic Markers in Idiopathic Pulmonary Fibrosis.

Lung·2026
Same journal

Nebulised heparin as a treatment for lung diseases: formulation challenges and pulmonary drug delivery strategies.

Lung·2026
Same journal

Social Vulnerability Index is Associated with Increased Risk of Malignancy in Screen-Detected High-Risk Pulmonary Nodules.

Lung·2026
Same journal

Validation Approaches for Cough Monitoring Tools: A Scoping Review.

Lung·2026
Same journal

Serological Profiling and Neuro-Immune Resilience: The Dissociation Between Anti-SARS-CoV-2 Antibodies and Post-Viral Airway Hyperresponsiveness in Pediatric Asthma.

Lung·2026
Same journal

Salvinorin A Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization and Macrophage-to-Myofibroblast Transition.

Lung·2026
See all related articles

Area of Science:

  • Cardiopulmonary physiology
  • Respiratory medicine
  • Sensory neuroscience

Background:

  • Dyspnea is a common symptom in cardiopulmonary diseases.
  • The precise mechanisms and physiological underpinnings of dyspnea are not fully elucidated.
  • Existing research suggests a multifactorial origin rather than a single causative factor.

Purpose of the Study:

  • To explore the underlying mechanisms of dyspnea.
  • To review methods for quantifying the sensation of dyspnea.
  • To assess current and potential therapeutic strategies for dyspnea.

Main Methods:

  • Review of existing literature on dyspnea.
  • Analysis of physiological factors contributing to the sensation.
  • Evaluation of clinical quantification techniques, including exercise-based assessments.

Related Experiment Videos

  • Examination of pharmacological interventions.

    • Main Results:

    • The sensation of dyspnea likely involves reflex increases in central respiratory motor output and respiratory muscle activity.
    • No single specific site or receptor has been identified as solely responsible for dyspnea.
    • The role of chemical drives (hypoxia, hypercapnia) in directly causing dyspnea remains uncertain.
    • Exercise-based methods using visual analogue or Borg scales are clinically applicable for quantifying dyspnea.
    • Treatments for dyspnea are largely experimental; exercise conditioning effects are unclear, and while some drugs show promise, none are routinely recommended.

    Conclusions:

    • Dyspnea results from a complex interplay of neural and muscular factors.
    • Clinical quantification is feasible using validated scales, particularly with exercise stimuli.
    • Effective, evidence-based treatments for dyspnea are still under development, necessitating further research.